• Company Type For Profit
  • Contact Email
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.

Lists Featuring This Company

RA Capital Management Portfolio Companies
202 Number of Organizations ? $43.3B Total Funding Amount ? 2,199 Number of Investors
Europe Startups Founded in 2017
2,752 Number of Organizations ? $11.4B Total Funding Amount ? 6,088 Number of Investors
Scandinavia Startups Founded in 2017
249 Number of Organizations ? $920.3M Total Funding Amount ? 571 Number of Investors
European Union (EU) Companies (Top 10K)
9,953 Number of Organizations ? $402.4B Total Funding Amount ? 35,024 Number of Investors